ChemoMetec A/S

Copenhagen Stock Exchange CHEMM.CO

ChemoMetec A/S Revenue for the year ending June 30, 2024: USD 58.73 M

ChemoMetec A/S Revenue is USD 58.73 M for the year ending June 30, 2024, a -9.55% change year over year. Revenue is the total amount of money generated from the sales of goods or services by a company during a specific period.
  • ChemoMetec A/S Revenue for the year ending June 30, 2023 was USD 64.93 M, a 7.87% change year over year.
  • ChemoMetec A/S Revenue for the year ending June 30, 2022 was USD 60.19 M, a 34.28% change year over year.
  • ChemoMetec A/S Revenue for the year ending June 30, 2021 was USD 44.82 M, a 39.29% change year over year.
  • ChemoMetec A/S Revenue for the year ending June 30, 2020 was USD 32.18 M, a 20.70% change year over year.
Key data
Date Revenue Gross Profit Operating Income EBIT
Market news
Loading...
Copenhagen Stock Exchange: CHEMM.CO

ChemoMetec A/S

CEO Mr. Martin Helbo Behrens
IPO Date Dec. 18, 2006
Location Denmark
Headquarters Gydevang 43
Employees 174
Sector Health Care
Industries
Description

ChemoMetec A/S engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally. The company offers its solutions in are areas of cell-based therapy, cancer, and stem cell research, development, and manufacturing of pharmaceuticals as well as production and quality control of animal semen and beer. Its products include NucleoCounter NC-3000, an advanced image cytometer; NucleoCounter NC-250, an automated cell analyzer; NucleoCounter NC-202, a consistent cell counter; NucleoCounter NC-200, an automated cell counter that provides solution for cell counting and cell viability determination; NucleoCounter SP-100, an automated sperm cell counter for use in animal production; NucleoCounter SCC-100, a somatic cell counter used to measure the number of somatic cells in a milk sample; and NucleoCounter YC-100, an automated yeast cell counter used to measure the total cell count and viability of yeast cells in suspension. It also provides consumables comprising cassettes, reagents, and slides; accessories, which include cables, power supplies, software, and labware products, as well as service and validation plans. The company was incorporated in 1997 and is headquartered in Allerød, Denmark.

Similar companies

GMAB.CO

Genmab A/S

USD 216.88

1.28%

CBRAIN.CO

cBrain A/S

USD 24.73

1.41%

AMBU-B.CO

Ambu A/S

USD 18.73

1.26%

ZEAL.CO

Zealand Pharma A/S

USD 95.84

0.08%

ALK-B.CO

ALK-Abelló A/S

USD 20.15

-0.78%

StockViz Staff

January 15, 2025

Any question? Send us an email